Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Tomic, A., Skelly, D.T., Ogbe, A. et al.
Nature Communications – 13(1):1251.
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons.
Vahsen, B.F., Gray, E., Candalija, A. et al.
Scientific Reports – 12(1):12606.
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly, D.T., Harding, A.C., Gilbert-Jaramillo, J. et al.
Nature Communications – 12(1):5061.
Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium.
Vaughan-Jackson, A., Stodolak, S., Ebrahimi, K.H., Browne, C., Reardon, P.K., Pires, E., Gilbert-Jaramillo, J., Cowley, S.A, & James, W.S.
Stem Cell Reports – 16(7):1735-1748.
RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation.
Buchrieser, J., Oliva-Martin, M.J., Moore, M.D., Long, J.C,D., Cowley, S.A., Perez-Simón, J.A., James, W. and Venero, J.L.
Cell Death Dis. – 9(10): 973.
Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages.
Buchrieser, J., James, W. and Moore, M.D.
Stem Cell Reports – 8(2): 334-345.
A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.
Haenseler, W., Sansom, S.N., Buchrieser, J., Newey, S.E., Moore, C.S., Nicholls, F.J., Chintawar, S., Schnell, C., Antel, J.P., Allen, N.D., Cader, M.Z., Wade-Martins, R., James, W.S.* and Cowley, S.A.*
Stem Cell Reports – 8(6): 1727-1742.
The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4.
van Wilgenburg, B., Moore, M.D., James, W.S. and Cowley, S.A.
PLoS One – 9(1): e86071.
Company co-founded by Dunn School alumnus awarded £1.8 million to tackle Postoperative Delirium
Dr Benjamin Dodsworth completed his PhD in the Dunn School and went on to co-found and become the Chief Scientific Officer of PIPRA (Pre-Interventional Preventive Risk Assessment) based in Zurich, Switzerland. Founded in 2019, PIPRA is a digital health company that aims to combat Postoperative Delirium, the most common post-surgical complication affecting 20% of patients...